EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lymphoma and Long-Term cardiovascular disease risk: A comprehensive analysis from the UK biobank

Chenliang Ge, Yan He, Feng Huang, Zhiyu Zeng

Annals of Hematology · 25.08.2025 · 104 (11) · 5797-5808

DOI: 10.1007/s00277-025-06544-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 25.08.2025. Verfasst von Chenliang Ge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning, Guangxi, 530021, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Lymphoma, Biological Specimen Banks. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphoma survivors may face an increased risk of cardiovascular diseases (CVDs), but large-scale studies comprehensively assessing this risk are limited. This study aims to investigate the association between lymphoma and incident CVDs, and to explore differences across lymphoma subtypes and potential effect modifiers. This retrospective cohort study used UK Biobank data. 3,244 lymphoma patients were matched 1:5 to 16,208 non-cancer controls based on demographics, lifestyle, and health factors. Incident CVDs were ascertained from electronic health records. Multivariable Cox proportional hazards regression was used to assess the association between lymphoma and each cardiovascular outcome, adjusting for key demographic, lifestyle, and clinical factors. After multivariable adjustment, lymphoma was significantly associated with increased risks of myocarditis/pericarditis (HR: 3.24, 95% CI: 2.26-4.63), heart failure/cardiomyopathy (HR: 2.65, 95% CI: 2.26-3.11), atrial fibrillation/flutter (HR: 1.80, 95% CI: 1.58-2.04), valve diseases (HR: 1.80, 95% CI: 1.47-2.19), conduction system disease (HR: 1.65, 95% CI: 1.37-1.98), supraventricular arrhythmias (HR: 1.52, 95% CI: 1.07-2.17), peripheral arterial disease (HR: 1.47, 95% CI: 1.18-1.84), and ischemic heart disease (HR: 1.18, 95% CI: 1.04-1.34). Risk varied significantly across lymphoma subtypes, with Diffuse Large B-cell Lymphoma (DLBCL) and peripheral/cutaneous T-cell lymphomas exhibiting particularly elevated risks for several outcomes. Subgroup analyses indicated that age, sex, body mass index (BMI), and hypertension status significantly modified some associations. Lymphoma is associated with a significantly increased risk of multiple CVDs. Findings highlight the need for cardiovascular risk assessment and tailored management in lymphoma survivors, considering subtype and individual risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesLymphomaBiological Specimen BanksHumansMaleFemaleMiddle AgedUnited KingdomRetrospective StudiesAgedAdultRisk FactorsUK Biobank

Stichwörter der Autor:innen

CardiotoxicityCardiovascular diseaseCohort studyLymphomaUK biobank

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning, Guangxi, 530021, China.
  • School of Basic Medical Sciences, Guangxi Medical University, No.22 Shuangyong Road, Qingxiu District, Nanning, Guangxi, 530021, China.
  • Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention, Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, No.6 Shuangyong Road, Nanning, Guangxi, 53002…
  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning, Guangxi, 530021, China. zengzhiyu@gxmu.edu.cn.
  • School of Basic Medical Sciences, Guangxi Medical University, No.22 Shuangyong Road, Qingxiu District, Nanning, Guangxi, 530021, China. zengzhiyu@gxmu.edu.cn.

Förderung

  • Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention
  • Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases

Zitieren

APA

Ge, C., He, Y., Huang, F., & Zeng, Z. (2025). Lymphoma and Long-Term cardiovascular disease risk: A comprehensive analysis from the UK biobank. Annals of Hematology, 104(11), 5797-5808. https://doi.org/10.1007/s00277-025-06544-2

Vancouver

Ge C, He Y, Huang F, Zeng Z. Lymphoma and Long-Term cardiovascular disease risk: A comprehensive analysis from the UK biobank. Annals of Hematology. 2025;104(11):5797-5808. doi:10.1007/s00277-025-06544-2

BibTeX
@article{Ge2025,
  author = {Ge, Chenliang and He, Yan and Huang, Feng and Zeng, Zhiyu},
  title = {Lymphoma and Long-Term cardiovascular disease risk: A comprehensive analysis from the UK biobank},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {11},
  pages = {5797--5808},
  doi = {10.1007/s00277-025-06544-2}
}
Kostenlos starten →